More than 38 million Americans suffer from migraine. It is the sixth most disabling neurologic disease globally, according to the World Health Organization.
Yet, migraine often is undiagnosed and left untreated. Dr. Amaal Starling, a neurologist at Mayo Clinic, says because the neurologic disease is so incapacitating, it is important to have a variety of treatment options. Dr. Starling is the lead author of a new study that looked at single pulse transcranial magnetic stimulation for the preventive treatment of migraine.
A migraine. It’s much more than a headache. And it can be debilitating.
“It’s a neurologic disease that has light sensitivity, sound sensitivity, motion sensitivity, nausea, vomiting. There are so many components,” says Dr. Starling.
There is no cure for migraine but there is a new option cleared by the U.S. Food and Drug Administration for the acute and preventive treatment of migraine.
“The device is called a single-pulse transcranial magnetic stimulation device,” says Dr. Starling.
She says the device transmits a signal to the brain, reducing brain hyperexcitability.
“Place it on the back of the head just like that [beeping]’ and then you push these two buttons,” says Dr. Starling. “And that administers a pulse.”
The first step, says Dr. Starling, is to get people with migraine to their health care provider so they can be properly diagnosed and treated.
The Latest on: Migraine
via Google News
The Latest on: Migraine
- 11 Signs Your Headache Is Actually a Migraine on November 13, 2018 at 7:13 am
If you think your “really bad headaches” aren’t migraines, you may want to take a closer look at your symptoms—especially if you’re a woman. More than half of all migraine sufferers are never diagnose... […]
- Migraine Self-Care: Prepare for a Trip or Event on November 13, 2018 at 6:14 am
As a writer and travel consultant, I am often on the road, attending industry events, conducting research, and exploring destinations around the world. Travel and events can be taxing on even the heal... […]
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine on November 13, 2018 at 6:09 am
In a consensus statement by the European Headache Federation published in the Journal of Headache and Pain, researchers and pain experts formulated guidelines for the use of onabotulinumtoxinA for the ... […]
- Use of Narcotics for Migraine Treatment in the ED Has Dropped Significantly on November 12, 2018 at 1:21 pm
Over the years, the treatment of migraine in the emergency department (ED) has changed significantly. According to a new study, from 1999-2000 to 2014, the use of IV fluids, dopaminergic receptor anta... […]
- 5 Ways to Describe Hemiplegic Migraine on November 12, 2018 at 1:07 pm
A hemiplegic migraine is a rare form of migraine that is most often associated with one-sided numbness and paralysis of the head and body. The International Headache Society defines hemiplegic migrain... […]
- Considerations for Using CGRP Receptor Antagonists for Migraine on November 12, 2018 at 9:11 am
Peter Goadsby, MD, PhD; Jill Dehlin, RN; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, explain the importance of real-world data in determining the efficacy of CGRP (calcitonin gene-related peptide) ... […]
- Migraine and Heart Problems: When One Illness Leads to Another on November 12, 2018 at 3:36 am
Certain illnesses may put you at risk of having another—a so-called partner condition—come along for the ride. For instance, high blood pressure may help boost diabetes risks. Researchers aren’t alway... […]
- New migraine med developed by Aberdeen natives on November 10, 2018 at 4:12 am
When Ryan Darling and Kirk Johnson were growing up in Aberdeen, science was their thing. But they wouldn’t know each other until they met as scientists at the global pharmaceutical company Eli Lilly a... […]
- Doctors introduce a new once-a-month migraine treatment on November 4, 2018 at 5:25 am
Migraines are potentially debilitating headaches that cause millions of people to miss work and take all kinds of medications that only mask the symptoms. Now, the U.S. Food and Drug Administration ha... […]
via Bing News